Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-020917

Chief Financial Officer acquired 9,018 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2018-03-16 Other acquisition +9,018 154,365 D: show line 1 in the form
Loading xslF345X03/doc4.xml…